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Abstract

Literature Review

• The aim of the present review is to evaluate the efficacy and safety
of curcumin and fish oil as alternative or adjuvant treatments to
NSAIDs and immune modulating medications for the treatment of
chronic inflammation.
• An online search of CINAHL, PubMed, Cochrane and Alt
Healthwatch databases was conducted. It was limited to peerreviewed articles and clinical trials in academic journals within the
last ten years.
• Current research suggests that curcumin may be efficacious in the
treatment of chronic inflammation. It is generally regarded as safe
up to 12 gm/day with mild gastrointestinal effects but poor
bioavailability has limited its clinical application.
• Current research provides evidence that fish oil is efficacious for
the treatment of chronic inflammation in a variety of chronic
diseases. It is generally regarded as safe at doses of 3 gm/day with
mild gastrointestinal effects and no increased risk of bleeding.
• In vitro studies have demonstrated a synergistic anti-inflammatory
effect when curcumin and fish oil are used concomitantly.

Inflammation, Chronic Disease and Anti-Inflammatory Mechanisms
of Curcumin and Fish Oil
• Chronic inflammation creates a prolonged state of oxidative stress
and damage which may lead to the progression of many chronic
inflammatory and degenerative disorders.
• Curcumin exerts its anti-inflammatory effects by downregulating
inflammatory cytokines, enzymes and transcription factors.
• Fish oil exerts its anti-inflammatory effects by inhibiting neutrophil
recruitment, blocking production of pro-inflammatory
prostaglandins, leukotrienes, and cytokines, and inducing
macrophage phagocytosis and apoptotic cells.
Safety and Efficacy of NSAIDs and Immune Modulating Agents
• Panahi et al. found that in patients with osteoarthritis, analgesics
and NSAIDs, are only partially efficacious and their long-term use
has been associated with adverse effects.
• A systematic review by Garg et al. found the use of sulfasalazine,
mesalamine and immunosuppressives is efficacious for the
treatment of ulcerative colitis but is associated with high rates of
adverse effects.
• According to Chandran & Goel common adverse effects include
gastrointestinal bleeding, fluid retention, renal toxicity,
cardiovascular effects, accelerated osteoporosis,
myelosuppression, hepatotoxicity, ocular and auditory toxicity and
increased risk of infection.
Safety and Efficacy of Curcumin
• Bigford & Rossi found no significant differences in cognitive scores
and/or biological features of Alzheimer’s disease with unenhanced
curcumin but found it safe and tolerable up to 12 gms/day.
• Panahi et al. found 1500 mg/day of curcumin enhanced with
Bioperene may be efficacious in alleviating symptoms without
significant adverse effects in patients with knee osteoarthritis and
significantly decreased NSAID use.

Introduction
• Research has demonstrated that chronic inflammation may drive
many chronic diseases.
• Despite advances in the treatment of these complex chronic
diseases their occurrence rates have continued to increase.
• High costs and adverse effects of standard anti-inflammatory
treatments have prompted patients to seek more cost-effective and
non-toxic agents for their management.
• It is estimated that approximately 50% of Americans are
consuming dietary supplements to promote health and wellness.
• Curcumin and fish oil are two dietary supplements with
demonstrated anti-inflammatory properties.

Research Questions
• In patients with chronic inflammatory processes, is curcumin more
effective with fewer adverse effects than NSAIDs and immune
modulating agents at reducing inflammation?
• In patients with chronic inflammatory processes, is fish oil more
effective and with fewer adverse effects than NSAIDs and immune
modulating agents at reducing inflammation?
• In patients with chronic inflammatory processes, does concomitant
administration of curcumin and fish oil elicit a synergistic antiinflammatory effect?

•

•

•

Discussion
• Current mainstays of treatment for chronic inflammation are
NSAIDs and immune-modulating medications which are associated
with high rates of adverse effects.
• Current literature appears to provide evidence that curcumin may be
efficacious in the treatment of chronic inflammation in a variety of
chronic diseases with only mild gastrointestinal adverse effects
should its limitations with poor bioavailability be overcome.
• Current literature supports that fish oil taken at doses of > 2.7
gm/day is efficacious in reducing inflammation in a variety of chronic
diseases and is safe up to 3 mg daily with only mild gastrointestinal
adverse effects even in patients with high bleeding risk.
• Studies indicate that curcumin and fish oil may be a reasonable
alternative or adjunctive therapy in the treatment of chronic
inflammatory conditions and may decrease the need for NSAIDs and
immune modulating agents thus decreasing their adverse side effects.
• Due to different mechanisms of action in vitro studies provide
evidence of a synergistic anti-inflammatory effect when curcumin
and fish oil are given concomitantly. Human studies are needed.

Applicability to Clinical
Practice

Statement of the Problem
• Non-steroidal anti-inflammatory drugs (NSAIDs) and immune
modulating medications are the mainstays of treatment for chronic
inflammation yet their use is associated with a variety of adverse
effects which can limit or prevent their use.
• Methodologically robust studies are needed to evaluate if dietary
supplements can be effectively and safely used as alternative or
adjuvant treatments for chronic inflammation.

•

Safety and Efficacy of Fish Oil
Arriens et al. found fish oil improves quality of life, disease
activity, and biomarkers of inflammation with only mild
gastrointestinal adverse effects in patients with SLE.
A meta-analysis by Goldberg & Katz found fish oil improves pain
outcomes and reduced NSAID consumption at doses above 2.7
gm/day in patients with rheumatoid arthritis.
A systematic review by Lev-Tzion et al. found no evidence of
benefit of fish oil in maintaining remission of Crohn’s disease but
found no serious side effects.
Synergistic Effects of Curcumin and Fish Oil
Saw et al. found that curcumin and fish oil in vitro had a
synergistic anti-inflammatory effect and concluded there is strong
evidence these effects may be translated into human trials.

(Frequency of the use of NSAIDs/painkillers at baseline and at the
end of study. Overall, the proportion of subjects reporting no or
decreased use of NSAIDs (naproxen) at the end of study was
significantly greater in the curcumin versus placebo group
(p < 0.001).
• Chandran & Goel found 1 gm/day of enhanced BCM-95 curcumin
alone or in combination with diclofenac sodium decreased CRP
levels without any significant adverse effects but was similar if
efficacy to placebo in reducing joint tenderness and swelling in
patients with rheumatoid arthritis.
• Panahi et al. found 1 gm/day of curcumin enhanced with piperine
as compared to placebo improves biomarkers of systemic
antioxidant, lipid peroxidation and inflammation in patients with
metabolic syndrome.
• Lang et al. found 3 gm/day of unenhanced Cur-Cure curcumin in
addition to optimized mesalamine therapy was superior to placebo
in inducing clinical and endoscopic remission without increased
rates of adverse effects in patients with ulcerative colitis.

• In patients who desire to use dietary supplements to treat chronic
inflammation there is evidence that curcumin and fish oil may be
efficacious with only mild gastrointestinal adverse effects and may
help reduce NSAID use.
• Curcumin may be efficacious in doses ranging from 500 mg/day
to 12 mg/day in a variety of chronic diseases. A bioavailability
enhanced formulation should be used.
• Fish oil may be efficacious in a variety of chronic diseases at a
dose of 3 gm/day with no increased risk of bleeding. There does
not appear to be evidence to support the efficacy and safety of
higher doses.
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